NEW YORK (GenomeWeb) – Thermo Fisher Scientific has completed the analytical validation of its universal companion diagnostic test that it is developing with Pfizer and Novartis, the company said this week.
NEW YORK (GenomeWeb) – Thermo Fisher Scientific has completed the analytical validation of its universal companion diagnostic test that it is developing with Pfizer and Novartis, the company said this week.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.